Archives of Medical Research
Volume 40, Issue 7 , Page 640 , October 2009

Iron, γ-Glutamyltransferase, and Atherosclerosis

  • Luca Mascitelli

      Affiliations

    • Comando Brigata Alpina “Julia”, Medical Service, Udine, Italy
    • Corresponding Author InformationAddress reprint requests to: Luca Mascitelli, M.D., Comando Brigata Alpina “Julia”, Medical Service, 8 Via S. Agostino, Udine 33100, Italy, Phone: +390432584044, FAX: +390432584053
    • ,
  • Francesca Pezzetta

      Affiliations

    • Ospedale di Tolmezzo, Cardiology Service, Tolmezzo, Italy
    • ,
  • Mark R. Goldstein

      Affiliations

    • Fountain Medical Court, Bonita Springs, FL

Received 23 September 2009 ,Accepted 25 September 2009.

References 

  1. Turgut O, Tandogan I, Gurlek A. Association of gamma-glutamyltransferase with cardiovascular risk: a prognostic outlook. Arch Med Res. 2009;40:318–320
  2. Sumida Y, Yoshikawa T, Okanoue T. Role of hepatic iron in non-alcoholic steatohepatitis. Hepatol Res. 2009;39:213–222
  3. Sullivan JL. The iron paradigm of ischemic heart disease. Am Heart J. 1989;117:1177–1188
  4. Lainé F, Reymann JM, Morel F, et al. Effects of phlebotomy therapy on cytochrome P450 2e1 activity and oxidative stress markers in dysmetabolic iron overload syndrome: a randomized trial. Aliment Pharmacol Ther. 2006;24:1207–1213

PII: S0188-4409(09)00186-6

doi: 10.1016/j.arcmed.2009.10.003

Archives of Medical Research
Volume 40, Issue 7 , Page 640 , October 2009

Article Tools